Recent agreements between the federal government and leading pharmaceutical manufacturers, Novo Nordisk (maker of Ozempic, Wegovy) and Eli Lilly (maker of Mounjaro, Zepbound), will significantly reduce the cost of these drugs for Medicare and Medicaid patients, as well as for those paying out of pocket
The most commonly reported include: Nausea Constipation or diarrhoea Heartburn or reflux Feeling overly full Reduced appetite that can lead to under-eating Practical pharmacist guidance that helps: Smaller meals, slower eating, prioritise protein and fibre Hydration targets and electrolytes when needed Dose timing strategies and symptom tracking Reviewing other medicines (some can worsen nausea or constipation) Seek urgent medical advice for severe or persistent symptoms, especially severe abdominal pain, vomiting that does not settle, or signs of dehydration
doi: 10.2147/CLEP.S179083 31 FuruKWettermarkBAndersenMMartikainenJEAlmarsdottirABSorensenHT
This allows you to focus on transforming your health without wrestling with cumbersome paperwork
A chart usually assumes a low C-rate or resting state
In fact, GLP-1 medications carry an FDA black box warning regarding the risk of medullary thyroid carcinoma (MTC)
